In a recent Swedish publication, the percentage of carriers of a pathogenic variant in BRCA1 or BRCA2 among women diagnosed with breast cancer at 40 years or younger was 10.0% (105/1055 patients) [5]. This evidence concerns the gene BRCA1 and breast carcinoma.